SlideShare une entreprise Scribd logo
1  sur  10
GlaxoSmithKline
Scandal

Shiqiao Peng
History and Background
• The GlaxoSmithKline (GSK) is “a science-led healthcare company that
researches and develops a broad range of innovative medicines and
brands”.
• LOCATION With the headquarters in the UK, GSK has offices in more than
115 countries, such as UK, USA, Spain, Belgium, and China.
• GOAL “We are dedicated to improving the quality of human life by enabling
people to do more, feel better, and live longer.”
• GSK China GSK is one of the largest transnational pharmacy organizations
in China. GSK has invested over 500 million dollars and has created more
than 7,000 jobs and running a number of factories in China.
The Scandal
• In June 2013, news reports pointed out that GSK’s staff bribed doctors to
prescribe drugs . Xinhua news agency reported that a Glaxo sales manager
said that the company’s representatives “established good personal
relations with doctors by catering to their pleasure or offering them money,
in order to make them prescribe more drugs”.
• GSK issued a statement telling that no evidence has found to support that
report.
• The Ministry of Public Security in China conducted investigation into the
organization and found Glaxo used bribes and other benefits for doctors
and other public officials to increase its sales. The payments for doctors
and officials were “funneled through travel agencies, totaling approximately
$450 million”.
• 18 more Glaxo employees had been detained in the city of Zhengzhou,
Henan Province on July 26.
Organizational Response
• Verbal Response
• July 11: We take all allegations of bribery and corruption seriously. We
continuously monitor our businesses to ensure they meet our strict
compliance procedures. We have done thins in China and found no
evidence of bribery or corruption of doctors or government officials.
However, if evidence of such activity is provided, we will act swiftly on it.
• July 15: GSK “shares the desire of the Chinese authorities to root out
corruption” and that GSK will “take all necessary action required by the
outcome of this investigation”
• July 22: Certain senior executives of GSK China who know our systems
well, appear to have acted outside of our processes and controls which
breaches Chinese law

• Non-Verbal Response
Media Response
• The Focus Report (CCTV) produced an episode telling the story of GSK
crisis on July 16. The episode’s name is Reveal the untold story of GSK. The
program explaines how GSK use travel agency to briber doctors and
officials. Besides, it also blames GSK to spend the money on bribery and
transfer the cost to customers. Another CCTV program News One Plus
One also blamed GSK in a feature story, saying GSK’s advertisement of its
fast growth in China is more like an irony today.
• Baidu.com lists the timeline and news reports of GSK crisis on the right side
of the website when you search “GSK” through baidu.com. East Moring
News, Beijing Commercial Newspaper, China Daily, People Net, Southern
Daily News, NTES Finance, Jinghua Times, Xinjin News, Beijing Youths
Newspaper, and all major newspapers published news reports as the crisis
progressed.
Stakeholders Response
• Chinese Government
• Medical Industry
• Hospitals and Doctors
• Other Foreign Firms in China
• Ordinary Customers and Netizens
Recommendations

• Environmental scanning
• Internal Communication
• Be careful with the statement
References

AFP. (2013, July 25). Glaxo replaces chief of China unit at center of bribery inquiry. New York Times.
Retrieved from:
http://www.nytimes.com/2013/07/26/business/glaxo-replaces-chief-of-china-unit-at-center-of-bribery-inquiry.html
Barboza, D. (2013, July 11). GlaxoSmithKline accused of corruption by China. New York Times. Retrieved
from: http://www.nytimes.com/2013/07/12/business/global/china-accuses-glaxosmithkline-ofcorruption.html?_r=0
Barboza
, D. (2013, July 17). China bars GlaxoSmithKline executive from leaving a bribery inquiry. New York Tim
es. Retrieved from: http://www.nytimes.com/2013/07/18/business/global/china-bars-glaxosmithklineexecutive-from-leaving.html
Barboza, D. (2013, July 26). China details allegations against Glaxo. New York Times. Retrieved from:
http://
www.nytimes.com/2013/07/27/business/global/china-details-allegations-against-glaxo.html?_r=0
GSK China. (2013). GSK in China. Retrieved from: http://www.gsk-china.com/chinese/html/aboutus/gskchina.html
GSK. (2013a). About us. Retrieved from: http://www.gsk.com/about-us.html
GSK. (2013b). China investigation. Retrieved from:
http://www.gsk.com/media/resource-centre/china-investigation.html
GSK. (2013c). GSK statement regarding recent meeting with Chinese authorities. Retrieved from:
http://www.gsk.com/media/press-releases/2013/gsk-statement-regarding-re
cent-meeting-with-chinese-authorities.html
Henning, P. (2013, July 29). Lessons from the Glaxo Case in China. New York Times. Retrieved from:
http://dealbook.nytimes.com/2013/07/29/lessons-from-the-glaxosmithkline-case-in-china/
Jack, A., Jenkins, P. & Oakley, D. (2013, Septem
ber, 23). GlaxoSmithKline China sales face growing pressure. Ft.com. Retrieved from:
http://www.ft.com/intl/cms/s/0/20e5fe62-2462-11e3-8905-00144feab7de.html#axzz2iNzupy5X
Roland, D. (2013, July 24). Glaxo in China: History of a crisis. The Telegraph. Retrieved from:
http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/10200321/Glaxoin-China-History-of-a-crisis.html
Thank you!
Thank you!

Contenu connexe

En vedette

Use of Microfluidic Capillary Gel Electrophoresis for Release and Stability T...
Use of Microfluidic Capillary Gel Electrophoresis for Release and Stability T...Use of Microfluidic Capillary Gel Electrophoresis for Release and Stability T...
Use of Microfluidic Capillary Gel Electrophoresis for Release and Stability T...
Mike Smith
 
Cases in reward management
Cases in reward managementCases in reward management
Cases in reward management
claireloney
 
Uber Presentation
Uber PresentationUber Presentation
Uber Presentation
Kyle Lake
 

En vedette (18)

Use of Microfluidic Capillary Gel Electrophoresis for Release and Stability T...
Use of Microfluidic Capillary Gel Electrophoresis for Release and Stability T...Use of Microfluidic Capillary Gel Electrophoresis for Release and Stability T...
Use of Microfluidic Capillary Gel Electrophoresis for Release and Stability T...
 
Stock specific report on godfrey phillips
Stock specific report on godfrey phillipsStock specific report on godfrey phillips
Stock specific report on godfrey phillips
 
Tcs
TcsTcs
Tcs
 
Cases in reward management
Cases in reward managementCases in reward management
Cases in reward management
 
GlaxoSmithKline Bribery & Corruption Case
GlaxoSmithKline Bribery & Corruption CaseGlaxoSmithKline Bribery & Corruption Case
GlaxoSmithKline Bribery & Corruption Case
 
Uber Presentation
Uber PresentationUber Presentation
Uber Presentation
 
Hr issues in mergers & acquisitions gcm
Hr  issues in mergers & acquisitions gcmHr  issues in mergers & acquisitions gcm
Hr issues in mergers & acquisitions gcm
 
GSK Horlicks Presentation
GSK Horlicks PresentationGSK Horlicks Presentation
GSK Horlicks Presentation
 
Corporate social responsibility
Corporate social responsibilityCorporate social responsibility
Corporate social responsibility
 
Eva And Compensation Management System At Tata Consultancy
Eva And Compensation Management System At Tata ConsultancyEva And Compensation Management System At Tata Consultancy
Eva And Compensation Management System At Tata Consultancy
 
Mergers and acquisition
Mergers and acquisitionMergers and acquisition
Mergers and acquisition
 
Career Development at GlaxoSmithKline Pakistan (HRM: AHK)
Career Development at GlaxoSmithKline Pakistan (HRM: AHK)Career Development at GlaxoSmithKline Pakistan (HRM: AHK)
Career Development at GlaxoSmithKline Pakistan (HRM: AHK)
 
Tcs
TcsTcs
Tcs
 
Human Resource Aspect of Mergers and Acquisition - Presentation - Karim Virani
Human Resource Aspect of Mergers and Acquisition - Presentation - Karim ViraniHuman Resource Aspect of Mergers and Acquisition - Presentation - Karim Virani
Human Resource Aspect of Mergers and Acquisition - Presentation - Karim Virani
 
Challenges in HRM in MNCs
Challenges in HRM in MNCsChallenges in HRM in MNCs
Challenges in HRM in MNCs
 
PERFORMANCE APPRAISAL AND CASE STUDY ON MICROSOFT
PERFORMANCE APPRAISAL AND CASE STUDY ON MICROSOFTPERFORMANCE APPRAISAL AND CASE STUDY ON MICROSOFT
PERFORMANCE APPRAISAL AND CASE STUDY ON MICROSOFT
 
Human Resoruce - Training and development (GSK Glaxosmithkline India)
Human Resoruce - Training and development (GSK Glaxosmithkline India)Human Resoruce - Training and development (GSK Glaxosmithkline India)
Human Resoruce - Training and development (GSK Glaxosmithkline India)
 
Gsk m anagement
Gsk m anagementGsk m anagement
Gsk m anagement
 

Dernier

Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
WSO2
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Victor Rentea
 

Dernier (20)

Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
Biography Of Angeliki Cooney | Senior Vice President Life Sciences | Albany, ...
 
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
Apidays New York 2024 - APIs in 2030: The Risk of Technological Sleepwalk by ...
 
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost SavingRepurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
Repurposing LNG terminals for Hydrogen Ammonia: Feasibility and Cost Saving
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdfRising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
Rising Above_ Dubai Floods and the Fortitude of Dubai International Airport.pdf
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamDEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
 
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
Navigating the Deluge_ Dubai Floods and the Resilience of Dubai International...
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024Finding Java's Hidden Performance Traps @ DevoxxUK 2024
Finding Java's Hidden Performance Traps @ DevoxxUK 2024
 
ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challenges
 
CNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In PakistanCNIC Information System with Pakdata Cf In Pakistan
CNIC Information System with Pakdata Cf In Pakistan
 
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024
 
MS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsMS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectors
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 

Gsk crisis ppt

  • 2. History and Background • The GlaxoSmithKline (GSK) is “a science-led healthcare company that researches and develops a broad range of innovative medicines and brands”. • LOCATION With the headquarters in the UK, GSK has offices in more than 115 countries, such as UK, USA, Spain, Belgium, and China. • GOAL “We are dedicated to improving the quality of human life by enabling people to do more, feel better, and live longer.” • GSK China GSK is one of the largest transnational pharmacy organizations in China. GSK has invested over 500 million dollars and has created more than 7,000 jobs and running a number of factories in China.
  • 3. The Scandal • In June 2013, news reports pointed out that GSK’s staff bribed doctors to prescribe drugs . Xinhua news agency reported that a Glaxo sales manager said that the company’s representatives “established good personal relations with doctors by catering to their pleasure or offering them money, in order to make them prescribe more drugs”. • GSK issued a statement telling that no evidence has found to support that report. • The Ministry of Public Security in China conducted investigation into the organization and found Glaxo used bribes and other benefits for doctors and other public officials to increase its sales. The payments for doctors and officials were “funneled through travel agencies, totaling approximately $450 million”. • 18 more Glaxo employees had been detained in the city of Zhengzhou, Henan Province on July 26.
  • 4. Organizational Response • Verbal Response • July 11: We take all allegations of bribery and corruption seriously. We continuously monitor our businesses to ensure they meet our strict compliance procedures. We have done thins in China and found no evidence of bribery or corruption of doctors or government officials. However, if evidence of such activity is provided, we will act swiftly on it. • July 15: GSK “shares the desire of the Chinese authorities to root out corruption” and that GSK will “take all necessary action required by the outcome of this investigation” • July 22: Certain senior executives of GSK China who know our systems well, appear to have acted outside of our processes and controls which breaches Chinese law • Non-Verbal Response
  • 5. Media Response • The Focus Report (CCTV) produced an episode telling the story of GSK crisis on July 16. The episode’s name is Reveal the untold story of GSK. The program explaines how GSK use travel agency to briber doctors and officials. Besides, it also blames GSK to spend the money on bribery and transfer the cost to customers. Another CCTV program News One Plus One also blamed GSK in a feature story, saying GSK’s advertisement of its fast growth in China is more like an irony today. • Baidu.com lists the timeline and news reports of GSK crisis on the right side of the website when you search “GSK” through baidu.com. East Moring News, Beijing Commercial Newspaper, China Daily, People Net, Southern Daily News, NTES Finance, Jinghua Times, Xinjin News, Beijing Youths Newspaper, and all major newspapers published news reports as the crisis progressed.
  • 6. Stakeholders Response • Chinese Government • Medical Industry • Hospitals and Doctors • Other Foreign Firms in China • Ordinary Customers and Netizens
  • 7. Recommendations • Environmental scanning • Internal Communication • Be careful with the statement
  • 8. References AFP. (2013, July 25). Glaxo replaces chief of China unit at center of bribery inquiry. New York Times. Retrieved from: http://www.nytimes.com/2013/07/26/business/glaxo-replaces-chief-of-china-unit-at-center-of-bribery-inquiry.html Barboza, D. (2013, July 11). GlaxoSmithKline accused of corruption by China. New York Times. Retrieved from: http://www.nytimes.com/2013/07/12/business/global/china-accuses-glaxosmithkline-ofcorruption.html?_r=0 Barboza , D. (2013, July 17). China bars GlaxoSmithKline executive from leaving a bribery inquiry. New York Tim es. Retrieved from: http://www.nytimes.com/2013/07/18/business/global/china-bars-glaxosmithklineexecutive-from-leaving.html Barboza, D. (2013, July 26). China details allegations against Glaxo. New York Times. Retrieved from: http:// www.nytimes.com/2013/07/27/business/global/china-details-allegations-against-glaxo.html?_r=0 GSK China. (2013). GSK in China. Retrieved from: http://www.gsk-china.com/chinese/html/aboutus/gskchina.html GSK. (2013a). About us. Retrieved from: http://www.gsk.com/about-us.html GSK. (2013b). China investigation. Retrieved from: http://www.gsk.com/media/resource-centre/china-investigation.html GSK. (2013c). GSK statement regarding recent meeting with Chinese authorities. Retrieved from: http://www.gsk.com/media/press-releases/2013/gsk-statement-regarding-re cent-meeting-with-chinese-authorities.html Henning, P. (2013, July 29). Lessons from the Glaxo Case in China. New York Times. Retrieved from: http://dealbook.nytimes.com/2013/07/29/lessons-from-the-glaxosmithkline-case-in-china/ Jack, A., Jenkins, P. & Oakley, D. (2013, Septem ber, 23). GlaxoSmithKline China sales face growing pressure. Ft.com. Retrieved from: http://www.ft.com/intl/cms/s/0/20e5fe62-2462-11e3-8905-00144feab7de.html#axzz2iNzupy5X Roland, D. (2013, July 24). Glaxo in China: History of a crisis. The Telegraph. Retrieved from: http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/10200321/Glaxoin-China-History-of-a-crisis.html

Notes de l'éditeur

  1. {}